Medicare Enrolled
Dr. David Levine, MD
Cardiovascular Disease · Dallas, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Levine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levine? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Levine
Dr. David Levine is a cardiovascular disease in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Levine performed 4,401 Medicare services across 2,249 unique beneficiaries.
Between the years covered by Open Payments, Dr. Levine received a total of $13,923 from 48 pharmaceutical and/or device companies across 837 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Levine is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 21% volume in TX$ $13,923 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,401
Medicare services
Top 21% in TX for cardiovascular disease
2,249
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~232 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 1,217 | $6 | $34 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 1,067 | $20 | $67 |
| Remote pacemaker monitoring, 90 days | 353 | $23 | $77 |
| Office visit, established patient (20-29 min) | 325 | $66 | $233 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 293 | $28 | $103 |
| Hospital follow-up visit, moderate complexity | 180 | $62 | $180 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 166 | $20 | $67 |
| Electrocardiogram (EKG), 12-lead | 133 | $11 | $36 |
| Hospital follow-up visit, low complexity | 126 | $38 | $96 |
| Initial hospital admission, moderate complexity | 121 | $101 | $340 |
| Programming of dual lead pacemaker system | 86 | $46 | $203 |
| Programming of multiple lead implantable defibrillator system | 49 | $69 | $272 |
| Programming of multiple lead pacemaker system | 41 | $54 | $216 |
| Office visit, established patient (30-39 min) | 36 | $101 | $330 |
| Programming of dual lead implantable defibrillator system | 32 | $59 | $252 |
| New patient office visit (45-59 min) | 25 | $122 | $426 |
| Insertion of heart rhythm monitor under skin | 23 | $61 | $8,560 |
| Programming of cardiac rhythm monitor system | 23 | $40 | $153 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $357 | $1,288 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 18 | $201 | $991 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 16 | $354 | $1,148 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $640 | $2,046 |
| Insertion of implantable defibrillator system | 13 | $702 | $2,272 |
| External shock to heart to regulate heart beat | 13 | $78 | $690 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $684 | $2,747 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.1% high complexity
0.0% medium
78.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,923
Total received (2018-2024)
Avg $1,989/year across 7 years
Top 25% in TX for cardiovascular disease
48
Companies
837
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,923 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,674
2023$1,848
2022$1,594
2021$1,334
2020$1,267
2019$3,374
2018$2,833
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$2,019
Medtronic, Inc.
$1,831
Abbott Laboratories
$1,504
Boston Scientific Corporation
$1,480
Janssen Pharmaceuticals, Inc
$924
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$913
E.R. Squibb & Sons, L.L.C.
$853
Novartis Pharmaceuticals Corporation
$833
BOSTON SCIENTIFIC CORPORATION
$822
PFIZER INC.
$534
CARDIVA MEDICAL, INC.
$272
AstraZeneca Pharmaceuticals LP
$172
BIOTRONIK INC.
$160
Amarin Pharma Inc.
$152
Amgen Inc.
$129
Philips Electronics North America Corporation
$117
Bayer HealthCare Pharmaceuticals Inc.
$111
Merck Sharp & Dohme LLC
$93
Braemar Manufacturing, LLC
$82
SANOFI-AVENTIS U.S. LLC
$79
Bardy Diagnostics, Inc.
$68
Smith & Nephew, Inc.
$64
Aziyo Biologics, Inc.
$56
Inspire Medical Systems, Inc.
$48
Chiesi USA, Inc.
$46
Smith+Nephew, Inc.
$45
Alnylam Pharmaceuticals Inc.
$41
Lexicon Pharmaceuticals, Inc.
$39
Kiniksa Pharmaceuticals, Ltd.
$35
Silk Road Medical, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$32
Philips North America LLC
$31
GE HEALTHCARE
$30
Edwards Lifesciences Corporation
$28
Biosense Webster, Inc.
$24
CVRx, Inc.
$24
Stryker Corporation
$24
Vital Connect, Inc
$21
Itamar Medical Inc
$21
Lundbeck LLC
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$17
CHIESI USA, INC.
$16
Ethicon US, LLC
$15
ABIOMED
$13
Novo Nordisk Inc
$13
Teleflex LLC
$13
Allergan Inc.
$12
Top 3 companies account for 38.5% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (7999) SRC Undivided · (CK4) MCOT · ACCOLADE SR · ADVISOR · ANTHEM · ASSURITY · AVEIR · AZURE XT DR MRI SURESCAN · Adapta · Advisa · Advisor Catheter · Allia · Arcalyst · Assurity Pacemaker · Azure · BELSOMRA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDENE · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CLEVIPREX · COBALT DR MRI SURESCAN · COMPIA MRI QUAD CRT-D SURESCAN · CONFIRM RX · COREVALVE EVOLUT R · CRT-Ds · Cardiac Monitoring Suite · Cardiva VASCADE MVP VVCS 6-12F · CareLink · Carnation Ambulatory Monitor · Catheter - Turnpike · Claria MRI · Cobalt · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · DYNAGEN · ECM Patch · ELIQUIS · EMBLEM · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENDOTAK · ENROUTE Transcarotid Stent · ENSITE · ENSITE PRECISION · ENTRESTO · Edarbyclor · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · Evera · FARXIGA · FlexAbility Ablation Catheter · GENERAL TACHY · GENERAL THERAPIES · GENERAL - BRADY · GENERAL - THERAPIES · GENERAL BRADY · GENERAL THERAPIES · General - Therapies · INSPIRE · Impella · Inpefa · JARDIANCE · JOT DX · KENGREAL · KENGREAL 50MG/10ML L · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LINQ II · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · N/A · NA · NORTHERA · ONPATTRO · Ozempic · PCI Optimization · PICO · PICO Single Use Negative Pressure Wound Therapy · PRALUENT · Percepta · Perclose ProGlide suture mediated closure system · Pouch · QUARTET · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RELIANCE 4 FRONT · RESONATE · Repatha · Reveal LINQ · S-ICD System Magnet · SQRX PULSE GENERATOR · STRATAFIX · SensiTherm (ICE) · TACTICATH · TYRX · TactiCath Quartz CFA Catheter · Tendril Pacing Lead · VANTAGEVIEW · VERQUVO · VIEWMATE · VIGILANT · VITALPATCH RTM · VYNDAQEL · Vascepa · Verquvo · Visia AF · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WORKMATE CLARIS · WatchPAT · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $316 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
299
Per 100K population
11.5
County median income
$74,149
Nearest hospital
METHODIST DALLAS MEDICAL CENTER
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Levine is a remote & electrophysiology specialist, with above-average Medicare volume (top 21% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Levine experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Levine performed 1,217 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levine receive payments from pharmaceutical companies?
Yes. Dr. Levine received a total of $13,923 from 48 companies across 837 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levine's costs compare to other cardiovascular diseases in Dallas?
Dr. Levine's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Dallas
Browse cardiovascular diseases in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology